Option Care Health (NASDAQ:OPCH) Sets New 12-Month High – Time to Buy?

Option Care Health, Inc. (NASDAQ:OPCH)’s share price reached a new 52-week high during mid-day trading on Monday . The company traded as high as $35.46 and last traded at $34.97, with a volume of 529 shares. The stock had previously closed at $34.58.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. UBS Group assumed coverage on shares of Option Care Health in a report on Thursday, December 5th. They set a “neutral” rating and a $26.00 target price for the company. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price objective for the company from $26.00 to $33.00 in a report on Monday, January 13th. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and upped their price objective for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. JPMorgan Chase & Co. upped their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a report on Thursday, March 6th. Finally, Barrington Research lifted their price target on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research report on Thursday, February 27th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and an average target price of $33.00.

Option Care Health Trading Up 1.0 %

The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The business’s fifty day simple moving average is $31.84 and its two-hundred day simple moving average is $28.29. The company has a market cap of $5.78 billion, a price-to-earnings ratio of 29.47, a PEG ratio of 2.30 and a beta of 1.33.

Insiders Place Their Bets

In other news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares of the company’s stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.64% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Option Care Health

Institutional investors have recently modified their holdings of the business. Murphy & Mullick Capital Management Corp acquired a new position in shares of Option Care Health in the 4th quarter valued at $26,000. UMB Bank n.a. increased its holdings in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after acquiring an additional 346 shares during the period. Signaturefd LLC increased its holdings in shares of Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after acquiring an additional 1,005 shares during the period. Quadrant Capital Group LLC increased its holdings in shares of Option Care Health by 172.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock valued at $40,000 after acquiring an additional 1,099 shares during the period. Finally, Public Employees Retirement System of Ohio increased its holdings in shares of Option Care Health by 21.6% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock valued at $43,000 after acquiring an additional 332 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.